Clinical Research Directory
Browse clinical research sites, groups, and studies.
Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
Sponsor: Fortis Medical Devices Limited
Summary
The goal of this clinical trial is to learn if the cueStim device can reduce the duration of freezing of gait (FoG) that occurs in patients with Parkinson's Disease. The study will compare two modes of operation of the cueStim device; both modes of operation use the same wearable device. The purpose of the study is to compare how the two modes affect symptoms across study participants. Because this is a research study, it is not yet known whether either mode reduces symptoms. Participants will: * Be randomized to one of the two modes available on the cueStim device * Wear the device for 4 weeks as they go about their daily life * Complete daily diary entries to document symptoms, falls and overall experience * Check-in with the clinical site throughout participation * Complete a final follow-up visit
Key Details
Gender
All
Age Range
60 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-10
Completion Date
2027-02
Last Updated
2026-06-30
Healthy Volunteers
No
Interventions
CueStim
Enrolled patients will be assigned to one of two modes and will be blinded to their assignment. The Device will be worn for four weeks throughout the patient's daily life. The patient will complete daily diary entries, periodically check in with the clinical staff, and complete questionnaires related to the impact of freezing of gait and Parkinson's Disease on daily life and function.
Locations (6)
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, United States
Arrow Clinical Trials
Daytona Beach, Florida, United States
Emory University
Atlanta, Georgia, United States
University of Kansas
Kansas City, Kansas, United States
Oregon Health and Science University
Portland, Oregon, United States
Evergreen Health Research Program
Kirkland, Washington, United States